EARLY CHANGES IN THE PERMEABILITY OF THE BLOOD-BRAIN-BARRIER PRODUCED BY TOXINS ASSOCIATED WITH LIVER-FAILURE

被引:27
作者
MCCLUNG, HJ
SLOAN, HR
POWERS, P
MEROLA, AJ
MURRAY, R
KERZNER, B
POLLACK, JD
机构
[1] CHILDRENS HOSP COLUMBUS,DEPT MED MICROBIOL & IMMUNOL,COLUMBUS,OH 43205
[2] CHILDRENS HOSP COLUMBUS,DEPT PHYSIOL CHEM,COLUMBUS,OH 43205
[3] OHIO STATE UNIV,COLL MED,COLUMBUS,OH 43210
关键词
D O I
10.1203/00006450-199009000-00014
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Our study was designed to determine whether substances that appear in the serum during the course of liver failure have a detrimental effect on the passive permeability of the blood-brain [blood-cerebrospi-nal fluid (CSF)] barrier. Lactic acid, octanoic acid, and ammonia were infused into rabbits for 4 h. The permeability changes of the blood-brain barrier were quantified by infusing polyethylene glycol 400 (PEG 400) and measuring the quantity and average mol wt of the PEG 400 that entered the CSF. The lipid solubility and effective diffu-sional radius of the PEG molecules were also quantified to provide greater precision for measurements using this probe. None of the animals receiving toxic infusions became seriously ill during the infusions. Low dose infusions of lactic acid, octanoic acid, and ammonia increased the effective pore diameter of the blood-brain barrier from 7.3 Å to an average of 8.5 Å. The amount of PEG entering the CSF increased from 1.7 to 4.0 (p < 0.025), 4.7 (p < 0.025), and 6.7 (p < 0.001) mmol/L, respectively. Rabbits with galactosamine-induced liver failure had 10.1 mmol/L PEG 400 in the CSF (p> 0.001) before any evidence of cerebral edema. These changes occur soon after these toxins accumulate in the plasma and may alone or together with other toxins account for the permeability changes that allow aeurotoxic substances to enter the brain during hepatic disease and encephalopathies such as Reye’s syndrome. © 1990 International Pediatric Research Foundation, Inc.
引用
收藏
页码:227 / 231
页数:5
相关论文
共 35 条
[1]  
BLITZER BL, 1978, GASTROENTEROLOGY, V74, P664
[2]  
CHADWICK VS, 1977, GASTROENTEROLOGY, V73, P241
[3]   COMPARISON OF LIPID-MEDIATED BLOOD-BRAIN-BARRIER PENETRABILITY IN NEONATES AND ADULTS [J].
CORNFORD, EM ;
BRAUN, LD ;
OLDENDORF, WH ;
HILL, MA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 243 (03) :C161-C168
[4]   BIOCHEMICAL-MECHANISMS OF HEPATIC-ENCEPHALOPATHY [J].
CROSSLEY, IR ;
WARDLE, EN ;
WILLIAMS, R .
CLINICAL SCIENCE, 1983, 64 (03) :247-252
[5]  
Devivo D C, 1976, Adv Pediatr, V22, P175
[6]   HEPATIC-ENCEPHALOPATHY AND CEREBRAL EDEMA [J].
EDE, RJ ;
WILLIAMS, R .
SEMINARS IN LIVER DISEASE, 1986, 6 (02) :107-118
[7]   FILTRATION AND REFLECTION COEFFICIENTS OF RABBIT BLOOD-BRAIN BARRIER [J].
FENSTERMACHER, JD ;
JOHNSON, JA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1966, 211 (02) :341-+
[8]   METHODS FOR QUANTIFYING THE TRANSPORT OF DRUGS ACROSS BRAIN BARRIER SYSTEMS [J].
FENSTERMACHER, JD ;
BLASBERG, RG ;
PLATLAK, CS .
PHARMACOLOGY & THERAPEUTICS, 1981, 14 (02) :217-248
[9]   LATE ONSET HEPATIC-FAILURE - CLINICAL, SEROLOGICAL AND HISTOLOGICAL FEATURES [J].
GIMSON, AES ;
OGRADY, J ;
EDE, RJ ;
PORTMANN, B ;
WILLIAMS, R .
HEPATOLOGY, 1986, 6 (02) :288-294
[10]  
HOROWITZ ME, 1983, GASTROENTEROLOGY, V84, P1003